STVN
Stevanato Group SpA
NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$21.13
-1.17% today
Updated 2026-09-25
Market cap
$5.87B
P/E ratio
38.41
P/S ratio
4.79x
EPS (TTM)
$0.56
Dividend yield
—
52W range
$13 – $28
Volume
0.4M
Stevanato Group SpA (STVN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$21.13
12-Month target
$14.34
2030 Target
—
Intrinsic (DCF)
$46.57
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.8B | $1.0B | $1.1B | $1.1B | $1.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 11.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.